Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | AMGN | VRTX | REGN | BMY |
| Company | Eidos Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 127.57 | 314.82 | 430.93 | 988.00 | 45.00 |
| High | 128.49 | 321.44 | 439.26 | 988.96 | 45.17 |
| Low | 116.83 | 312.87 | 428.62 | 966.34 | 44.54 |
| Last | 122.21 | 319.30 | 437.46 | 978.27 | 44.58 |
| Change | -6.23 | +7.89 | +8.87 | -6.37 | -0.13 |
| % Change | -4.85% | +2.53% | +2.07% | -0.65% | -0.29% |
| Volume | 335,500 | 1,701,815 | 484,108 | 328,273 | 5,021,715 |
| 20-Day Average Volume | 113,985 | 2,872,616 | 1,077,126 | 450,212 | 13,981,684 |
| Previous Close | 128.44 | 311.41 | 428.59 | 984.64 | 44.71 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 288.80 | 407.56 | 931.24 | 45.50 |
| 20-Day Raw Stochastic | 36.63% | 94.43% | 98.31% | 89.48% | 20.43% |
| 20-Day Relative Strength | 56.42% | 68.88% | 69.37% | 60.89% | 35.95% |
| Weighted Alpha | +136.62 | +42.94 | +30.38 | +29.88 | -33.08 |
| Today's Opinion | 88% Buy | 72% Buy | 56% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 100% Buy | 56% Buy | 56% Buy | 72% Buy | 100% Sell |
| Last Month's Opinion | 100% Buy | 40% Sell | 24% Buy | 24% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | +3.85% since 05/08/24 | +4.69% since 05/08/24 | +2.22% since 05/08/24 | +2.14% since 05/08/24 |
| Low | 116.83 on 01/25/21 | 306.32 on 05/09/24 | 416.03 on 05/09/24 | 956.76 on 05/09/24 | 43.49 on 05/09/24 |
| High | 131.08 on 01/20/21 | 321.44 on 05/15/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 45.72 on 05/14/24 |
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | +20.20% since 04/15/24 | +10.34% since 04/15/24 | +8.73% since 04/15/24 | -8.05% since 04/15/24 |
| Low | 116.24 on 01/05/21 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 132.54 on 01/04/21 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 988.96 on 05/15/24 | 49.56 on 04/22/24 |
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | +10.41% since 02/15/24 | +2.85% since 02/15/24 | +2.33% since 02/15/24 | -9.78% since 02/15/24 |
| Low | 69.38 on 10/30/20 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 132.54 on 01/04/21 | 322.60 on 05/03/24 | 439.26 on 05/15/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | +16.89% since 11/15/23 | +25.51% since 11/15/23 | +23.30% since 11/15/23 | -13.51% since 11/15/23 |
| Low | 38.44 on 07/31/20 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 785.83 on 11/16/23 | 43.33 on 05/02/24 |
| High | 132.54 on 01/04/21 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 167,051,216 | 110,598,944 | 108,493,528 | 90,631,640 |
| Shares Outstanding, K | 38,873 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 26,690,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -37,840,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 130,000 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 11,865,000,000 |
| Last Quarter Net Income | -30,180,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | -11,911,000,000 |
| 60-Month Beta | -0.16 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 02/24/21 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.56 | 28.55 | 26.33 | 42.91 |